For the treatment of arthritis, competition exists in both the prescription market and the OTC market. The only true prescription competitos is Celebrex, as Vioxx and Bextra have been pulled from the market due to concerns about side effects. Major OTC competitors are Aleve, Excedrin, and aspirin. New competitors on the prescription front, although not publicly well-known, are Enbrel, Remicade, and Avara. For the treatment of migraines, competition exists in both the prescription and OTC markets. Common prescription competitive medications for the treatment of migraines are Imitrex, Axert, and Midrin. The OTC counterparts are Excedrin Migraine and Advil Migraine. Next, there is strong competition in the OTC market for a general fever/pain reliever from many well-known brand names and generics. Aspirin makers Bayer and Excedrin are the major brand players for an otherwise generic product. Acetaminophen is a competing product, most often associated with the Tylenol brand. NExt, there is ibuprofen with common brand names of Motrin and Advil. Finally, there is Aleve, which employs naproxen sodium as its active ingredient. Fianlly, VirPharm could look at a different market for the product, such as offering the product as a multisymptpm treatment. In this arena, competition comes from many of the same organizations, which supply multisymptom products such as Tylenol Cold, Advil Cold & Sinus, and Nyquil.
đang được dịch, vui lòng đợi..